Junru Feng

Hunan University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index291citations17works15.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(6), RNA Research and Splicing(5), Asphalt Pavement Performance Evaluation(3), RNA and protein synthesis mechanisms(2), Pancreatic function and diabetes(2)

Publications17 total

A polymeric cationic asphalt emulsifier for low-carbon and renewable pavements: Investigating its dual effects of modification and emulsification on asphalt
Construction and Building Materials·2025· 5 cited
Investigation on the pavement performance and application of cold mix emulsified asphalt mixture in the surface layer
Journal of Cleaner Production·2025· 9 cited
Effect of novel warm-mix compound on road performance and aging resistance of SBR-modified bituminous mixture
Construction and Building Materials·2025· 1 cited
Carnosine regulation of intracellular pH homeostasis promotes lysosome-dependent tumor immunoevasion
Nature Immunology·2024· 45 cited
Data from DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing
2023Open Access
Supplementary Figure S1-S5, and Tables S1-S8 from DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing
2023Open Access
Supplementary Figure S1-S5, and Tables S1-S8 from DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing
2023Open Access
Data from DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing
2023Open Access
Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps
Nature Communications·2023· 49 citedOpen Access
Non‐canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism
The EMBO Journal·2022· 30 citedOpen Access
Analysis of Mobile Game Intellectual Property Marketing Strategy: A Case Study of Honor of Kings
Applied Economics and Finance·2022· 2 citedOpen Access
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
Protein & Cell·2022· 45 citedOpen Access
Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase
Cell Death and Disease·2021· 15 citedOpen Access
Glycine cleavage system determines the fate of pluripotent stem cells via the regulation of senescence and epigenetic modifications
Life Science Alliance·2019· 28 citedOpen Access
DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing
Cancer Research·2019· 48 citedOpen Access
Everolimus Shows Synergistic Antimyeloma Effects with Bortezomib via the AKT/mTOR Pathway
Journal of Investigative Medicine·2018· 14 cited
Discovery of a novel and selective IDO-1 inhibitor PF-06840003 and its characterization as a potential clinical candidate.
2017

Frequent Co-authors

Huafeng Zhang(10), Linchong Sun(9), Shengqi Shen(9), Weidong Jia(9), Ping Gao(7), Xiuying Zhong(7), Songge Xing(5), Zhaoyong Li(5), Xiaoping He(5), Shiting Li(5), Yuhao Huangfu(5), Lanhong Su(5), Xiaozhang Zhang(5), Wenhao Ma(4), Haoran Wei(4), Wenhao Ma(4), Haoran Wei(4), Ying Shu(4), Ping Gao(4), Zilong Zhou(3)